GENFIT Announces Publication of the 2022 Universal Registration Document and the 2022 Annual Report on Form 20-F
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); April 18, 2023 – GENFIT (Nasdaq and…
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); April 18, 2023 – GENFIT (Nasdaq and…
Lille (France); Cambridge (Massachusetts, United States); Zurich (Switzerland); April 18, 2023 – GENFIT (Nasdaq and…
BOSTON, April 18, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…
BOSTON, April 18, 2023 (GLOBE NEWSWIRE) — Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), an immuno-oncology company…
● ZW191 demonstrates strong responses in FRα-low expressing patient-derived xenograft (PDX) models with favorable pharmacokinetic…
● ZW191 demonstrates strong responses in FRα-low expressing patient-derived xenograft (PDX) models with favorable pharmacokinetic…
SEATTLE, April 18, 2023 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a…
SEATTLE, April 18, 2023 (GLOBE NEWSWIRE) — Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a…
Two oral presentations scheduled for Thursday, April 27, 2023 WARMINSTER, Pa., April 18, 2023 (GLOBE…
Two oral presentations scheduled for Thursday, April 27, 2023 WARMINSTER, Pa., April 18, 2023 (GLOBE…
Key Presentation Highlights Ability of ONC201 to Reverse Epigenetic Signature of H3 K27M Mutation in…
Key Presentation Highlights Ability of ONC201 to Reverse Epigenetic Signature of H3 K27M Mutation in…
SOMERVILLE, Mass., April 18, 2023 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics”…
JENA, Germany, April 18, 2023 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX) (the “Company”), a…
MALVERN, Pa., April 18, 2023 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
Add-on value-added service provides ultra-fast, ultra-reliable, and cost-efficient connectivity to enterprise, industrial, and transportation critical…
SAN DIEGO, April 18, 2023 (GLOBE NEWSWIRE) — QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or…
Improved API based on the RouteSavvy route optimization engine offers significantly faster performance, ability to…
Toronto, Ontario–(Newsfile Corp. – April 18, 2023) – Deveron Corp. (TSXV: FARM) (“Deveron” or the…
Mississauga, Ontario–(Newsfile Corp. – April 18, 2023) – Cipher Pharmaceuticals (TSX: CPH), a specialty pharmaceutical…